Evidence map›Paper›PMID 40346019›Full record

Trial reportPhysiological reports2025

Acute kaempferol ingestion lowers oxygen uptake during submaximal exercise and improves high-intensity exercise capacity in well-trained male athletes.

Koichi Okita, Tsubasa Mizokami, Osamu Yasuda, Yasutaka Ikeda

Erratum issuedAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Physiological reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Koichi OkitaHokusho University Graduate School of Lifelong Sport, Bunkyodai Ebetsu, Hokkaido, Japan.
Tsubasa MizokamiSaga Nutraceuticals Research Institute, Nutraceuticals Division, Otsuka Pharmaceutical Co., Ltd., Yoshinogari-cho, Saga, Japan.
Osamu YasudaDepartment of Sports and Life Sciences, National Institute of Fitness and Sports in Kanoya, Kanoya, Kagoshima, Japan.
Yasutaka IkedaAdvanced Research Institute for Core Science, Nutraceuticals Division, Otsuka Pharmaceutical Co., Ltd., Konan, Minato-ku, Tokyo, Japan.ORCID 0000-0002-9128-279X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Our previous study involving 314 highland crop species demonstrated that kaempferol, a flavonoid present in higher amounts in these species, significantly enhances mitochondrial metabolism and cellular ATP production in myoblasts under limited oxygen conditions. Notably, biologically active substances in these plants, such as phytochemicals, may help improve the health and physical strength of highland residents. Therefore, we hypothesized that kaempferol would affect oxygen availability during exercise and exercise performance in vivo. This randomized, double-blind, placebo-controlled crossover study aimed to assess the effect of a single kaempferol intake (10 mg) on cardiopulmonary response during submaximal exercises (25%, 50%, and 75% VO

Indexed as

ExerciseExercise ToleranceKaempferolsOxygen ConsumptionAdministration, OralAdultAthletesCross-Over StudiesDouble-Blind MethodHumansMalePhysical EnduranceYoung AdultkaempferolKaempferolsergogenic aidhighlandhypoxiakaempferoloxidative metabolismphytochemical

Identifiers

PMID40346019
PMCPMC12064338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.